Related Experiment Video
Updated: Aug 4, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis in Poland in 2020
Maria Korzeniewska-Koseła1, Stefan Wesołowski2
1Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute.
Tuberculosis (TB) incidence in Poland significantly decreased by 36.7% in 2020, a decline not seen in two decades. Poland also reported higher bacteriological confirmation rates and lower multidrug-resistant TB (MDR-TB) percentages compared to EU/EEA countries.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health challenge, necessitating ongoing surveillance and analysis of epidemiological trends.
- Understanding the specific epidemiology of TB in Poland and its comparison with European Union/European Economic Area (EU/EEA) countries is crucial for targeted public health interventions.
- The year 2020 presented unique circumstances potentially impacting disease patterns due to global events.
Purpose of the Study:
- To evaluate the primary epidemiological features of tuberculosis (TB) in Poland during 2020.
- To compare the TB situation in Poland with that of other European Union and European Economic Area (EU/EEA) countries.
- To identify trends and variations in TB incidence, drug resistance, and demographic distribution within Poland.
Main Methods:
- Analysis of case-based data from the National TB Register for 2020.
- Inclusion of data on anti-TB drug susceptibility, mortality statistics from 2019, and information on HIV-positive individuals with TB.
- Utilized data from the European Centre for Disease Prevention and Control and WHO reports for comparative analysis.
Main Results:
- Poland reported 3,388 TB cases in 2020, with an incidence rate of 8.8 per 100,000 population, showing significant regional variability.
- A notable 36.7% decrease in TB incidence was observed compared to 2019, the largest decline in two decades.
- Pulmonary TB constituted 95.5% of cases, with bacteriological confirmation in 79.5% and multidrug-resistant TB (MDR-TB) in 1.6% of cases with known drug sensitivity.
Conclusions:
- The substantial decrease in TB incidence in Poland in 2020 is a significant public health achievement.
- Poland demonstrated higher bacteriological confirmation rates and a lower proportion of MDR-TB compared to EU/EEA averages.
- Higher TB incidence was observed in older age groups and in men, with migration having a limited impact on the overall TB pattern in 2020.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders

